Movement - uncoordinated and Multiple sclerosis relapse

Summary:

Multiple sclerosis relapse is found among people with Movement - uncoordinated, especially for people who are female, 30-39 old.

The study analyzes which people have Multiple sclerosis relapse with Movement - uncoordinated. It is created by eHealthMe based on reports of 53 people who have Movement - uncoordinated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Movement - uncoordinated?

Movement - uncoordinated is found to be associated with 1,103 drugs and 2,268 conditions by eHealthMe. Check the latest studies of Movement - uncoordinated.

What is Multiple sclerosis relapse?

Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,032 drugs and 943 conditions by eHealthMe. Check the latest studies of Multiple sclerosis relapse.

On Aug, 03, 2026

53 people who have Movement - Uncoordinated and Multiple Sclerosis Relapse are studied.

Would you have Multiple sclerosis relapse when you have Movement - uncoordinated?

Gender of people who have Movement - Uncoordinated and experienced Multiple Sclerosis Relapse *:

female: 79.25 %
male: 20.75 %

Age of people who have Movement - Uncoordinated and experienced Multiple Sclerosis Relapse *:

Common co-existing conditions for these people *:

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 31 people, 58.49%
Fatigue (feeling of tiredness): 24 people, 45.28%
Depression: 20 people, 37.74%
High Blood Pressure: 20 people, 37.74%
Pain: 19 people, 35.85%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 15 people, 28.30%
Gait Disturbance: 13 people, 24.53%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 5 people, 9.43%
Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 3.77%
Erection Problems: 2 people, 3.77%

Common drugs taken by these people *:

Ampyra: 33 people, 62.26%
Amlodipine: 20 people, 37.74%
Baclofen: 13 people, 24.53%
Ocrevus: 12 people, 22.64%
Tecfidera: 12 people, 22.64%
Amitriptyline Hydrochloride: 11 people, 20.75%
Avonex: 11 people, 20.75%
Amantadine: 11 people, 20.75%
Pregabalin: 11 people, 20.75%
Synthroid: 10 people, 18.87%

Common symptoms for these people *:

Cough: 24 people, 45.28%
Gait Disturbance: 23 people, 43.40%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 22 people, 41.51%
Neuralgia (pain in one or more nerves): 22 people, 41.51%
Fall: 21 people, 39.62%
Pain: 20 people, 37.74%
Weight Increased: 19 people, 35.85%
Heart Rate Increased: 19 people, 35.85%
Hair Loss: 19 people, 35.85%
Breast Lump (localized swelling that feels different from the surrounding breast tissue): 19 people, 35.85%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Multiple sclerosis relapse?

- Check whether Multiple sclerosis relapse is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Multiple sclerosis relapse and Movement - uncoordinated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.